Search | Page 19 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: What do hospitalists need to know?

    ... are three standard approaches, including agents such as azacitidine (Vidaza®) and decitabine (Dacogen®), intensive ... and stem cell transplantation.  Patients tend to tolerate azacitidine and decitabine fairly well.  These agents appear to restore normal ...

    Research Review last updated 05/02/2016 - 9:21am.

  2. Clinical Utility of Lenalidomide in the Treatment of Myelodysplastic Syndromes

    ... to examine the combination of hypomethylating agent azacitidine and lenalidomide. The verdict is still out whether regarding ...

    Research Review last updated 05/02/2016 - 9:12am.

  3. What are the treatments for MDS?

    ... lenalidomide (Revlimid), decitaibine (Dacogen) and azacitidine (Vidaza). Chemotherapy :  Treats MDS by using ...

    FAQ last updated 03/15/2016 - 11:31pm.

  4. Therapies

    ... are three medicines approved in the U.S. to treat MDS. Azacitidine (Vidaza®) and decitabine (Dacogen®) are approved to ...

    Page last updated 03/18/2016 - 11:26am.

  5. Treatments

    ... are three medicines approved in the U.S. to treat MDS. Azacitidine (Vidaza®) and decitabine (Dacogen®) are approved to ...

    Topic section last updated 03/30/2016 - 3:13pm.

  6. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... Associated Drug(s):  Azacitidine Phase:  ... dose (MTD) from Phase I. Other Names: Azacitidine 5-aza Vidaza 5-AZC AZA-CR ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  7. Clinical Trial Basics

    ... (Revlimid) eculizumab (Soliris) azacitidine (Vidaza) eltrombopag (Promacta) Research has also ...

    Page last updated 03/29/2016 - 7:29pm.

  8. Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes

    ... Associated Drug(s):  Azacitidine Phase:  ... Intervention:  Drug: CC-486 (ORAL AZACITIDINE) 200 mg CC-486 (Oral Azacitidine) will be given for the first 21 ...

    Clinical Trial last updated 04/19/2016 - 12:22pm.

  9. FAQs

    ... (Revlimid), decitabine (Dacogen) and azacitidine (Vidaza). Chemotherapy treats MDS by using drugs ... (Revlimid®) decitabine (Dacogen®) and azacitidine (Vidaza®). Learn more about treatments for MDS. For PNH ...

    Topic section last updated 03/02/2016 - 11:42am.

  10. Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (ICT-HCT)

    ... Associated Drug(s):  Azacitidine Decitabine ... Intervention:  Drug: Azacitidine Given IV or SC Other Names: 5 ...

    Clinical Trial last updated 04/27/2016 - 9:41am.